Clinical Trials Browser

Phase 2 × Lung Neoplasms × Fluorodeoxyglucose F18 × Clear all

NCT02448225 2022-10-19

18F-FSPG PET/CT in Imaging Patients With Newly Diagnosed Lung Cancer or Indeterminate Pulmonary Nodules

Phase 2 Completed

46 enrolled 12 charts

Cigarette Smoking, Solitary Pulmonary Nodule, Lung Neoplasms

NCT00953459 2018-07-26

Sunitinib Malate in Treating Patients With Small Cell Lung Cancer

Phase 2 Terminated

Lung Neoplasms, Small Cell Lung Carcinoma

NCT00958321 2017-05-24

Positron Emission Tomography and Computed Tomography in Planning Treatment for Patients Undergoing 3-Dimensional Conformal Radiation Therapy for Non-Small Cell Lung Cancer That Cannot Be Removed by Surgery. ICORG 06-35

Phase 2 Terminated

Adenocarcinoma of Lung, Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Neoplasm Metastasis, Pleural Effusion, Malignant

NCT00227539 2017-05-09

Positron Emission Tomography in Predicting Response in Patients Who Are Undergoing Treatment With Pemetrexed Disodium and Cisplatin With or Without Surgery for Stage I, Stage II, or Stage III Non-Small Cell Lung Cancer

Phase 2 Completed

25 enrolled 8 charts

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT00083083 2011-03-01

Fludeoxyglucose F18 Positron Emission Tomography Imaging In Assessing Patients Before and After Treatment for Locally Advanced Non-Small Cell Lung Cancer

Phase 2 Unknown

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms